News / Health

Experimental Malaria Vaccine Falls Short

A mother holds her baby as she receives a new malaria vaccine at the Walter Reed Project Research Center in Kenya, October 30, 2009. A mother holds her baby as she receives a new malaria vaccine at the Walter Reed Project Research Center in Kenya, October 30, 2009.
x
A mother holds her baby as she receives a new malaria vaccine at the Walter Reed Project Research Center in Kenya, October 30, 2009.
A mother holds her baby as she receives a new malaria vaccine at the Walter Reed Project Research Center in Kenya, October 30, 2009.
VOA News
The world's first experimental malaria vaccine produced disappointing results in a large-scale test among African infants, raising questions about its potential for fighting the disease.

The vaccine, promoted as a new weapon in the malaria fight, reduced the risk of malaria by only 30 percent. The study involved more than 6,500 babies aged six to 12 weeks.

The results, released Friday, showed the vaccine providing less than half the protection it did in a previous smaller trial involving infants. The report said the "modest protection" the vaccine, which is also known as RTS,S or Mosquirix, has been provided in this latest trial was also lower than the 50 percent reported last year among older children.

Dr. Jennifer Cohn, a doctor with Doctors Without Borders, told the Associated Press that the vaccine’s effectiveness was “unacceptably low.”

Vaccinating babies is seen as a more cost effective way of battling the disease since it could be added to the regimen of other infant vaccinations.

Billionaire Microsoft founder and philanthropist Bill Gates, whose foundation is helping fund the vaccine, said the effectiveness rate came back lower than hoped.

But the top British drug manufacturer developing the vaccine, GlaxoSmithKline (GSK), will continue its efforts. Chief executive Andrew Witty said the drugmaker remains convinced the vaccine has a role to play in tackling malaria.

“We’ve been at this for 30 years, and we’re certainly not going to give up now, he said during a conference call with reporters.

The company, which has invested $300 million in the drug, does not expect to profit from the drug, which will be sold only in poor countries.

“The results look bad now, but they will probably be worse later,” said Adrian Hill of Oxford University to the Associated Press.

The results were released during a conference in South Africa Friday as part of a continuing study that will end in 2014.

The World Health Organization estimates that more than 650,000 people die from the mosquito-borne illness each year. The vast majority are children in sub-Saharan Africa.

You May Like

Video Experts Warn World Losing Ebola Fight

Doctors Without Borders says world is losing battle against Ebola, unless wealthy nations dispatch specialized biological disaster response teams More

Video Experts: Rise of Islamic State Significant Development in Jihadism

Many analysts contend the group - which grew out of al-Qaida in Iraq - has been rebuilding for years More

US-Based Hong Kongers Pledge Support for Pro-Democracy Activists

Democracy advocates call on Chinese living abroad to join them in opposing new election rules for their home territory More

This forum has been closed.
Comment Sorting
Comments
     
by: Karel Eekels from: Middleburg, Virginia
December 02, 2012 6:31 PM
Plasmodium Falciparum is the parasite causing malignant malaria in humans. I strongly suggest for interested parties to google this.

MMS (Miracle Mineral Solution) consists of chlorine dioxide. Lemon and especially apple cider vinegar generates chlorine dioxide on a smaller scale (than the on the market available MMS
solution) it oxidizes the pathogens and kills or eliminates to a large extend the pathogens and has no side effects.

Jim Humble who came up with this formula treated thousands and thousands of malaria patients on the African and South American continent that were doomed with great success but was and continues to be shunned as a voodoo practitioner by the medical and pharmaceutical industry. Wonder why?? Is there not enough money to be made on this? I always have this on me when I work and have my boots on the ground in these regions.

Respectfully submitted.

Karel Eekels


by: Sawaki from: Japan
November 14, 2012 6:05 PM
Africa is important for our world economic growth, while we can not expect Europe and the United States.
So we need to invest for Africa and save the children's life from deadly diseases.


by: Anonymous
November 09, 2012 3:05 PM
It's worth the fight! Please keep of the valiant efforts of solving this evil virus.

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Larger Than Life Chinese Lanterns Make Southern California Appearancei
X
Elizabeth Lee
September 02, 2014 8:57 PM
Chinese lanterns with a long history are lighting up in 21st century style at the Los Angeles County Fair in southern California. Visitors can see traditional lanterns that hang, but also lanterns in the shape of animals, iconic landmarks and many other objects, all created by artisans from a place in China known for its lanterns. Elizabeth Lee has the details from the fair in the city of Pomona.
Video

Video Larger Than Life Chinese Lanterns Make Southern California Appearance

Chinese lanterns with a long history are lighting up in 21st century style at the Los Angeles County Fair in southern California. Visitors can see traditional lanterns that hang, but also lanterns in the shape of animals, iconic landmarks and many other objects, all created by artisans from a place in China known for its lanterns. Elizabeth Lee has the details from the fair in the city of Pomona.
Video

Video Experts See Rise of ISIS as Significant Development

The Islamic State’s rise seems sudden. It caught the U.S. by surprise this summer when it captured large portions of northern Iraq and spread its wings in neighboring Syria. But many analysts contend that the group - which grew out of al-Qaida in Iraq - has been rebuilding for years. VOA's Jela de Franceschi takes a closer look at the rise of ISIS and its implications for the Middle East and beyond.
Video

Video Israel Concerned Over Syrian Rebels in Golan

Israeli officials are following with concern the recent fighting between Syrian rebels and government forces near the contested Golan Heights. Forty-four U.N. peacekeepers from Fiji have been seized by Syrian Islamist rebels and the clashes occasionally have spilled into Israel. VOA’s Scott Bobb reports from Jerusalem.
Video

Video Ukraine Schools Resume Classes, Donate to Government Forces

A new school year has started in Ukraine but thousands of children in the war-torn east are unable to attend because of ongoing clashes with pro-Russia rebels. In Ukraine's capital, patriotic education has become the norm along with donations to support injured security forces fighting to take back rebel-held areas. VOA's Daniel Schearf reports from Kyiv.
Video

Video US Detainees Want Negotiators for Freedom in North Korea

The three U.S. detainees held in North Korea were permitted to speak with foreign media Monday. The government of Kim Jong Un restricted the topics of the questions, and the interviews in Pyongyang were limited to five minutes. Each of the men asked Washington to send a representative to Pyongyang to secure his release. VOA’s Carolyn Presutti has our story.
Video

Video Turkmen From Amerli Describe Survival of IS Siege

Over the past few weeks, hundreds of Shi'ite Turkmen have fled the town of Amerli seeking refuge in the northern city of Kirkuk. Despite recent military gains after U.S. airstrikes that were coordinated with Iraqi and Kurdish forces, the situation remains dire for Amerli’s residents. Sebastian Meyer went to Kirkuk for VOA to speak to those who managed to escape.
Video

Video West Africa Ebola Vaccine Trials Possible by Early 2015

A U.S. health agency is speeding up clinical trials of a possible vaccine against the deadly Ebola virus that so far has killed more than 1,500 people in West Africa. If successful, the next step would be a larger trial in countries where the outbreak is occurring. VOA's Carol Pearson has more.
Video

Video Survivors Commemorate 70th Anniversary of Nazi Liquidation of Jewish Ghetto

When the German Nazi army occupied the Polish city of Lodz in 1939, it marked the beginning of a long nightmare for the Jewish community that once made up one third of the population. Roughly 200,000 people were forced into the Lodz Ghetto. Less than 7,000 survived. As VOA’s Kane Farabaugh reports, some survivors gathered at the Union League Club in Chicago on the 70th anniversary of the liquidation of the Lodz Ghetto to remember those who suffered at the hands of the Nazi regime.

AppleAndroid